To find the highest tolerable dose of JV-213 (a type of autologous CAR T cell therapy) that can be given to patients who have B-cell lymphoma that is relapsed …

LymphomasB-cell Lymphomas

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT05773040

Phase 2

Phase 2 Study of Glofitamab and Gemcitabine and Oxaliplatin (Glofit-GemOx) Bridging to Lisocabtagene Maraleucel in Relapsed/Refractory Aggressive B-cell Lymphomas

The goal of this clinical trial is to assess the clinical efficacy of bridging therapy with glofitamab/gemcitabine/oxaliplatin (Glofit-GemOx) followed by lisoc…

LymphomaB-cell LymphomasRelapsed/Refractory Large B-cell Lymphoma+1 more

~Estimated

~$10 – $6,250

Massachusetts General HospitalNCT07711483